We find here that patients with the high M-RiskScore have frequently NPM1 mutation (as the top three mutated genes), hinting that NPM1 mutation would be associated with the inactive gene expression of HMMRs in AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.